CFDE Data Portal | Search UPK3B

	Label	Description
	UPK3B associations Collection (Entity type)	Associations for UPK3B_associations
	UPK3B associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	UPK3B Gene (Entity type)	ENSG00000243566 - uroplakin 3B
	KFGENEBIN:UPK3B-variant-count CUI gene has variants UPK3B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE145990 1 V 0 IBRUTINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 15 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE197555 0 V 3 TRAMETINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE216988 GSE216989 decitabine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE149880 2 V 1 TAMOXIFEN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

UPK3B associations

Associations for UPK3B_associations

UPK3B associations.tsv

A file from IDG as part of the Harmonizome project

UPK3B

ENSG00000243566 - uroplakin 3B

KFGENEBIN:UPK3B-variant-count CUI gene has variants UPK3B

A Knowledge Graph Assertion from Kids First

GSE145990 1 V 0 IBRUTINIB HUMAN UP

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 15 human dn

A Gene Set from LINCS

GSE239844 crizotinib 6 v 9 human up

A Gene Set from LINCS

GSE197555 0 V 3 TRAMETINIB HUMAN UP

A Gene Set from LINCS

GSE216988 GSE216989 decitabine 0 v 1 human up

A Gene Set from LINCS

GSE149880 2 V 1 TAMOXIFEN MOUSE DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.